Functional brain imaging of movement disorders

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Neurological Research

• Publication date

  2000-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/01616412.2000.11740675PMID 10769825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reproducibility of regional metabolic covariance patterns: comparison of four populations.

  1999cited by this paper
• GPi pallidotomy for dystonia: clinical outcome and neuronal activity.

  1998cited by this paper
• Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET

  1998cited by this paper
• Movement Disorders

  1998cited by this paper
• Pallidotomy for generalized dystonia

  1998cited by this paper
• Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease.

  1998cited by this paper
• Functional brain networks in movement disorders.

  1998cited by this paper
• Metabolic correlates of pallidal neuronal activity in Parkinson's disease.

  1997cited by this paper
• Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]Raclopride

  1997cited by this paper
• Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study.

  1997cited by this paper
• Stereotactic thalamotomy in tremor‐dominant Parkinson's disease: An H215O PET motor activation study

  1997cited by this paper
• Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms

  1997cited by this paper
• Preoperative indicators of clinical outcome following stereotaxic pallidotomy

  1997cited by this paper
• Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease

  1997cited by this paper
• Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1‐year results of a pilot study

  1996cited by this paper
• Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders.

  1996cited by this paper
• Regional metabolic correlates of surgical outcomes following unilateral pallidotomy for parkinson's disease

  1996cited by this paper
• Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.

  1995cited by this paper
• The metabolic topography of idiopathic torsion dystonia.

  1995cited by this paper
• Outcome after Stereotactic Thalamotomy for Dystonia and Hemiballismus

  1995cited by this paper
• Outcome after stereotactic thalamotomy for dystonia and hemiballismus.

  1995cited by this paper
• Stereotactic ventral pallidotomy for Parkinson's disease

  1995cited by this paper
• Early differential diagnosis of Parkinson's disease with 18F‐fluorodeoxyglucose and positron emission tomography

  1995cited by this paper
• Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia

  1995cited by this paper
• Functional Mapping of Sequence Learning in Normal Humans

  1995cited by this paper
• Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop.

  1995cited by this paper
• Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: A principal component approach to modeling brain function in disease

  1994cited by this paper
• The behavioural and motor consequences of focal lesions of the basal ganglia in man.

  1994cited by this paper
• Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms.

  1994cited by this paper
• Metabolic topography of the hemiparkinsonism‐hemiatrophy syndrome

  1994cited by this paper
• Network analysis of motor system connectivity in Parkinson's disease: Modulation of thalamocortical interactions after pallidotomy

  1994cited by this paper
• The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease.

  1994cited by this paper
• The Metabolic Topography of Parkinsonism

  1994cited by this paper
• Statistical parametric maps in functional imaging: A general linear approach

  1994cited by this paper
• Physiology of Basal Ganglia Disorders: An Overview

  1993cited by this paper
• Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography.

  1993cited by this paper
• Striatal 18F-DOPA Uptake: Absence of an Aging Effect

  1993cited by this paper
• Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias.

  1993cited by this paper
• A case of symptomatic hemidystonia improved by ventroposterolateral thalamic electrostimulation

  1993cited by this paper
• A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.

  1992cited by this paper
• Evidence for a common network of brain structures involved in parkinsonian tremor and voluntary repetitive movement.

  1992cited by this paper
• Core assessment program for intracerebral transplantations (CAPIT)

  1992cited by this paper
• A Regional Covariance Approach to the Analysis of Functional Patterns in Positron Emission Tomographic Data

  1991cited by this paper
• Thalamic stimulation for the treatment of tremor and other movement disorders.

  1991cited by this paper
• Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

  1990cited by this paper
• Neural mechanisms of dystonia: Evidence from a 2‐deoxyglucose uptake study in a primate model of dopamine agonist‐induced dystonia

  1990cited by this paper
• A hypothesis on the pathophysiological mechanisms that underlie levodopa‐ or dopamine agonist‐induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment

  1990cited by this paper
• The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

  1990cited by this paper
• Primate models of movement disorders of basal ganglia origin.

  1990cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper
• Multiple system atrophy--the nature of the beast.

  1989cited by this paper
• Thalamotomy in generalized dystonia.

  1988cited by this paper
• Scaled Subprofile Model: A Statistical Approach to the Analysis of Functional Patterns in Positron Emission Tomographic Data

  1987cited by this paper
• Validity and reliability of a rating scale for the primary torsion dystonias

  1985cited by this paper
• Stereotactic pallidotomy in extrapyramidal disorders.

  1985cited by this paper
• Stereotaxic thalamotomy in 55 cases of dystonia.

  1983cited by this paper
• Metabolic effects of unilateral lesion of the substantia nigra

  1981cited by this paper
• Activity‐dependent Energy Metabolism in Rat Posterior Pituitary Primarily Reflects Sodium Pump Activity

  1980cited by this paper
• 20-year followup study of the neurosurgical treatment of dystonia musculorum deformans.

  1976cited by this paper

• Metabolic Imaging of Deep Brain Stimulation in Meige Syndrome

  2022cites this paper
• Cortical hemodynamic mapping of subthalamic nucleus deep brain stimulation in Parkinsonian patients, using high-density functional near-infrared spectroscopy

  2021cites this paper
• Carbon-11 radiolabeling of iron-oxide nanoparticles for dual-modality PET/MR imaging.

  2013cites this paper
• Investigation of the neuroprotective effects of bee-venom acupuncture in a mouse model of Parkinson’s disease by using immunohistochemistry and In-vivo1H magnetic resonance spectroscopy at 9.4 T

  2013cites this paper
• Changes in brain glucose metabolism in subthalamic nucleus deep brain stimulation for advanced Parkinson's disease.

  2012cites this paper
• Neurotransmitter Release During Deep Brain Stimulation

  2012cites this paper
• Imaging in Parkinsonism and other extrapyramidal disorders

  2011cites this paper
• Rationale for Surgical Interventions in Movement Disorders

  2011cites this paper
• Combining functional imaging with brain stimulation in Parkinson's disease

  2011cites this paper
• Metabolic changes detected in vivo by 1H MRS in the MPTP‐intoxicated mouse

  2010cites this paper
• Basal Ganglia Circuits Underlying the Pathophysiology of Levodopa-Induced Dyskinesia

  2010cites this paper
• Deep Brain Stimulation: Technology at the Cutting Edge

  2010cites this paper
• Neuroimaging, Parkinson’s Disease

  2010cites this paper
• Feasibility of phase contrast radiography in cat normal spinal cord

  2008cites this paper
• Functional Imaging of Deep Brain Stimulation: fMRI, SPECT, and PET

  2008cites this paper
• Effects of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Olfactory Function in Parkinson’s Disease Patients

  2008cites this paper
• Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson’s disease, the MPTP‐intoxicated mouse

  2008cites this paper
• Genetic studies of diseases

  2007cites this paper
• Anatomy and physiology of the basal ganglia: relevance to Parkinson's disease and related disorders.

  2007cites this paper
• Chapter 16 – Hypokinesia and Hyperkinesia

  2007cites this paper
• The neural basis of functional neuroimaging signal with positron and single-photon emission tomography.

  2007cites this paper
• Phase contrast radiography of Lewy bodies in Parkinson disease

  2006cites this paper
• Anatomy and physiology of the basal ganglia: Implications for deep brain stimulation for Parkinson's disease

  2006cites this paper
• Deep brain stimulation for neurologic and neuropsychiatric disorders.

  2006cites this paper
• Neuroimaging in Parkinson’s Disease

  2005cites this paper
• Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features.

  2005cites this paper
• Distributed neural actions of anti-parkinsonian therapies as revealed by PET

  2005cites this paper
• Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters.

  2004cites this paper
• Effects of bilateral subthalamic nucleus stimulation on resting-state cerebral glucose metabolism in advanced Parkinson's disease.

  2004cites this paper
• Organization of midbrain dopamine systems and the pathophysiology of Parkinson's disease.

  2003cites this paper
• Pathophysiology of Parkinson's Disease: The MPTP Primate Model of the Human Disorder

  2003cites this paper
• Functional neuroanatomy of the basal ganglia in Parkinson's disease.

  2003cites this paper
• 122 NEUROCIRCUITRY OF PARKINSON ’ S DISEASE

  2002cites this paper
• Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease

  2002cites this paper
• Functional magnetic resonance imaging during deep brain stimulation: A pilot study in four patients with Parkinson's disease

  2001cites this paper